×
About 2,534 results

ALLMedicine™ Uterine Cancer Center

Research & Reviews  1,005 results

Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to pro...
https://doi.org/10.1016/j.canlet.2021.01.030
Cancer Letters; Kurnit KC, Draisey A et. al.

Feb 20th, 2021 - In many tumors, CD73 (NT5E), a rate-limiting enzyme in adenosine biosynthesis, is upregulated by TGF-β and drives tumor progression. Conversely, CD73 is downregulated in endometrial carcinomas (EC) despite a TGF-β-rich environment. Through gene ex...

Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies.
https://doi.org/10.1002/ijc.33470
International Journal of Cancer; O'Brien KM, Tworoger SS et. al.

Jan 12th, 2021 - When powder is applied to the genital area, it has the potential to reach internal reproductive organs and promote carcinogenesis by irritating and inflaming exposed tissues. Although many studies have considered the association between genital po...

Current status of cervical cytology during pregnancy in Japan.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790376
PloS One; Suzuki S, Hayata E et. al.

Jan 7th, 2021 - In Japan, uterine cancer screening during pregnancy is subsidized by public funds. We examined the current status of the results of cervical cytology conducted during pregnancy in Japan. We requested 2,293 obstetrical facilities to provide informa...

Universal screening for Lynch syndrome in uterine cancer patients: A quality improvemen...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577655
Gynecologic Oncology; Spinosa D, Acosta T et. al.

Jan 4th, 2021 - To determine the feasibility and effectiveness of a quality improvement initiative (QI) to adopt universal screening for Lynch syndrome in uterine cancer patients at an institution that previously employed age-based screening. Prior to the initiat...

DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation b...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773279
PloS One; Riggs MJ, Lin N et. al.

Dec 30th, 2020 - DACH1 is a transcriptional repressor and tumor suppressor gene frequently mutated in melanoma, bladder, and prostate cancer. Loss of DACH1 expression is associated with poor prognostic features and reduced overall survival in uterine cancer. In th...

see more →

Guidelines  9 results

Rising cancer incidence in younger adults: is obesity to blame?
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(19)30017-9/fulltext
Marinac,C.,et al

Feb 2nd, 2019 - Although cancer has historically been considered a disease of aging, a reported sharp rise in colorectal cancer incidence among adults aged 54 years and younger beginning in the mid-1980s for the colon and mid-1970s for the rectum has motivated re...

Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(18)30267-6/fulltext
Sung,H.,et al

Feb 2nd, 2019 - Cancer trends in younger adults, often under 50 years, reflect recent changes in carcinogenic exposures, which could foreshadow the future overall disease burden. Previous studies reported an increase in early onset colorectal cancer, which could ...

The Role of the Obstetrician–Gynecologist in the Early Detection of Epithelial Ovarian Cance...
https://www.sgo.org/wp-content/uploads/2012/09/CO-716.pdf
American College of Obstetricians and Gynecologists

Sep 2nd, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r.

Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Ear...
https://doi.org/10.1097/AOG.0000000000002289
Obstetrics and Gynecology;

Aug 23rd, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r...

Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detec...
https://doi.org/10.1097/AOG.0000000000002299
Obstetrics and Gynecology;

Aug 23rd, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r...

see more →

Drugs  89 results see all →

Clinicaltrials.gov  1,265 results

Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to pro...
https://doi.org/10.1016/j.canlet.2021.01.030
Cancer Letters; Kurnit KC, Draisey A et. al.

Feb 20th, 2021 - In many tumors, CD73 (NT5E), a rate-limiting enzyme in adenosine biosynthesis, is upregulated by TGF-β and drives tumor progression. Conversely, CD73 is downregulated in endometrial carcinomas (EC) despite a TGF-β-rich environment. Through gene ex...

Medroxyprogesterone acetate - medroxyprogesterone acetate tablet-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c8ffae3-3b3e-197e-e053-2a91aa0a59e3

Feb 11th, 2021 - Medroxyprogesterone Acetate Tablets USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicate...

Medroxyprogesterone acetate - medroxyprogesterone acetate tablet-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59cdc070-b4a2-1502-e053-2a91aa0a34fa

Feb 11th, 2021 - Medroxyprogesterone Acetate Tablets USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicate...

Progesterone - progesterone injection, solution-AuroMedics Pharma LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d19df3b-94ed-4681-beae-9caaf137d014

Jan 18th, 2021 - This drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer.

Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies.
https://doi.org/10.1002/ijc.33470
International Journal of Cancer; O'Brien KM, Tworoger SS et. al.

Jan 12th, 2021 - When powder is applied to the genital area, it has the potential to reach internal reproductive organs and promote carcinogenesis by irritating and inflaming exposed tissues. Although many studies have considered the association between genital po...

see more →

News  157 results

Radiotherapy for Rectal Cancer Linked to Risk for Later Malignant Gynecological Neoplasms
https://www.medscape.com/viewarticle/943852

Jan 10th, 2021 - (Reuters Health) - Women who receive radiotherapy for rectal cancer may be at an increased risk of uterine and ovarian cancer, a new study suggests. In an analysis of information from the SEER database on more than 20,000 female patients diagnosed...

Radiation's Role Questioned in Stage III Uterine Cancer
https://www.medpagetoday.com/hematologyoncology/othercancers/80497

Jun 14th, 2019 - Chemoradiotherapy (CRT) appeared to be no better than chemotherapy alone as adjuvant treatment for women with locally advanced endometrial cancer, the phase III GOG 258 trial found. At 5 years, 59% of women in the CRT arm were estimated to be aliv...

Hard-to-Treat Uterine Corpus Cancers Increasing
https://www.medpagetoday.com/hematologyoncology/othercancers/80074

May 26th, 2019 - Among all U.S. women, rates of more aggressive non-endometrioid cancer subtypes have been rising rapidly. And trends show marked racial differences and disparities, with higher rates of uterine corpus subtypes and poorer survival among non-Hispani...

Anomalous RT dose linked to lower survival in uterine cancer
https://www.mdedge.com/hematology-oncology/article/201155/gynecologic-cancer/anomalous-rt-dose-linked-lower-survival?channel=217
Bianca Nogrady

May 17th, 2019 - As many as one in eight patients with uterine cancer who undergo adjuvant radiation therapy may have been treated with doses that are inconsistent with standard practice, a new study suggests. Writing in JCO Clinical Cancer Informatics, Corbin D.

Rising cancer incidence in younger adults: is obesity to blame?
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(19)30017-9/fulltext
Marinac,C.,et al

Feb 2nd, 2019 - Although cancer has historically been considered a disease of aging, a reported sharp rise in colorectal cancer incidence among adults aged 54 years and younger beginning in the mid-1980s for the colon and mid-1970s for the rectum has motivated re...

see more →

Patient Education  9 results see all →